
Reset all filters
01 1Alexion Pharma Canada Corp.
02 2Alexion Pharma Canada, AstraZeneca Rare Disease
Reset all filters
01 12189015
02 12645810
03 13022097
Reset all filters
01 3Eculizumab
Reset all filters
01 3solution
Reset all filters
01 12015-05-01
02 22027-03-15
Patent Expiration Date : 2015-05-01
Date Granted : 2010-04-13
Brand Name : SOLIRIS
Patent Number : 2189015
Filing Date : 1995-05-01
Strength per Unit : 10 mg / mL
Dosage Form : solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2015-05-01
Date Granted : 2010-04-13
Patent Expiration Date : 2027-03-15
Date Granted : 2018-12-11
Brand Name : SOLIRIS
Patent Number : 2645810
Filing Date : 2007-03-15
Strength per Unit : 10 mg / mL
Dosage Form : solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2027-03-15
Date Granted : 2018-12-11
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2027-03-15
Date Granted : 2020-10-27
Brand Name : SOLIRIS
Patent Number : 3022097
Filing Date : 2007-03-15
Strength per Unit : 10 mg / mL
Dosage Form : solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2027-03-15
Date Granted : 2020-10-27
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF